Compare Sunrun Inc (RUN) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sunrun Inc vs TransMedics Group Inc — how do they compare? Sunrun Inc trades at $9.84 (market cap $2.42B), while TransMedics Group Inc trades at $87.08 (market cap $3.10B). The key difference: TransMedics Group Inc is the larger of the two by market cap, and TransMedics Group Inc is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals.
| RUN | TMDX | |
|---|---|---|
Market Cap | $2.42B | $3.10B |
Sector | Technology | Technology |
52-Week High | $21.41 | $150.42 |
52-Week Low | $9.38 | $61.99 |
Enterprise Value | $16.93B | $3.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sunrun (RUN) trades at $9.84, down 0.3% on the day, with bearish technical signals and mixed fundamentals. The stock shows attractive valuation metrics with P/E of 6.82 and P/B of 0.69, but faces operational challenges with negative operating cash flow. Recent Q2 2026 earnings beat expectations with $0.42 EPS versus $0.23 estimate, though guidance cuts and a Goldman Sachs price target reduction to $15 weighed on sentiment.
The outlook remains cautious despite strong analyst consensus (62% buy ratings) and $14.38 price target. Key opportunities include record storage attachment rates and securitization success, while risks involve negative cash flow trends, high debt levels (70.76% debt-to-asset ratio), and solar industry volatility. The stock trades 31.6% below analyst consensus target, offering potential upside if execution improves.
TransMedics Group (TMDX) trades at $87.02, down 1.57% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators like RSI indicate overbought conditions near 78. Fundamentally, the company reported record Q2 2026 revenue but missed earnings estimates, with net income margin declining to 22.69% from 31.42% in 2025. Recent news highlights an ongoing investigation into fiduciary duties by Rosen Law Firm, adding uncertainty.
The outlook remains cautiously optimistic with a consensus price target of $99.57, implying 14% upside, supported by strong analyst buy ratings (69%). However, risks include earnings volatility, margin pressure from rising costs, and legal scrutiny. Investors should weigh robust revenue growth against execution risks and elevated valuation multiples like a P/E of 23.15.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
